Literature DB >> 3533893

A method to generate microcells from human lymphoblasts for use in microcell mediated chromosome transfer.

D L Devore-Carter, E Pietrzak, S Kakati.   

Abstract

A method is described to generate microcells from human lymphoblasts for use in microcell-mediated chromosome transfer (MMCT). Micronuclei were induced in cells from a human lymphoblastic cell line by prolonged colcemid treatment, and were separated from these lymphoblasts by: attaching the cells to Concanavalin A coated plastic slides designed for enucleation, and centrifuging the slides in medium containing cytochalasin B. Microcells of less than 3 microns in diameter were fused with thymidine kinase negative mouse fibroblasts (LMTK-). HAT medium (hypoxanthine, aminopterin, and thymidine) was used to select microcell hybrids expressing thymidine kinase activity. Positive clones were isolated and Q-banded for chromosome analysis. Unlike previous methods, this procedure permits microcells to be easily generated from lymphoid cells. The methodology of enucleation of microcells may be extended to a variety of other donor cell types which can be micronucleated but which do not adhere tightly to enucleation slides and do not exhibit extrusion subdivision. This feature makes our methodology particularly useful for constructing a library of hybrid clones containing one or a few human chromosomes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533893     DOI: 10.1007/bf02623521

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  19 in total

1.  Studies of Interspecific (Rat x Mouse) Somatic Hybrids. I. Isolation, Growth and Evolution of the Karyotype.

Authors:  M C Weiss; B Ephrussi
Journal:  Genetics       Date:  1966-11       Impact factor: 4.562

2.  Phytohemagglutinin enhancement of cell fusion reduces polyethylene glycol cytotoxicity.

Authors:  W E Mercer; R A Schlegel
Journal:  Exp Cell Res       Date:  1979-05       Impact factor: 3.905

3.  Properties and uses of human-mouse hybrid cell lines.

Authors:  Y Matsuya; H Green; C Basilico
Journal:  Nature       Date:  1968-12-21       Impact factor: 49.962

4.  A method for enucleating cultured mammalian cells.

Authors:  T V Gopalakrishnan; E B Thompson
Journal:  Exp Cell Res       Date:  1975-12       Impact factor: 3.905

5.  A general high-efficiency procedure for production of microcell hybrids.

Authors:  R E Fournier
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

6.  Effects of cytochalasins on mammalian cells.

Authors:  S B Carter
Journal:  Nature       Date:  1967-01-21       Impact factor: 49.962

7.  Genetic manipulation by means of microcell-mediated transfer of normal human chromosomes into recipient mouse cells.

Authors:  C A McNeill; R L Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Human-mouse hybrid cell lines containing partial complements of human chromosomes and functioning human genes.

Authors:  M C Weiss; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

9.  Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells.

Authors:  R E Fournier; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

10.  Transfer of human chromosomes via human minisegregant cells into mouse cells and the quantitation of the expression of hypoxanthine phosphoribosyltransferase in the hybrids.

Authors:  A Tourian; R T Johnson; K Burg; S W Nicolson; K Sperling
Journal:  J Cell Sci       Date:  1978-04       Impact factor: 5.285

View more
  1 in total

1.  Panel of human cell lines with human/mouse artificial chromosomes.

Authors:  Narumi Uno; Shuta Takata; Shinya Komoto; Hitomaru Miyamoto; Yuji Nakayama; Mitsuhiko Osaki; Ryota Mayuzumi; Natsumi Miyazaki; Chiaki Hando; Satoshi Abe; Tetsushi Sakuma; Takashi Yamamoto; Teruhiko Suzuki; Yoshihiro Nakajima; Mitsuo Oshimura; Kazuma Tomizuka; Yasuhiro Kazuki
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.